Skip to main content
Sanjay Mathew, MD, Psychiatry, Houston, TX

Sanjay J. Mathew MD


Professor; and Chair for Research in Psychiatry, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine. Staff Physician, Michael E. Debakey Veterans Affairs Medical Center.

Join to View Full Profile
  • 1977 Butler BoulevardSuite E4.189Houston, TX 77030

  • Phone+1 713-798-5877

Dr. Mathew is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute
    New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1997 - 2001
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1997

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2025
  • TX State Medical License
    TX State Medical License 2010 - 2025
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)  
    Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature
  • Endogenous Opioid System Dysregulation in Depression: Implications for New Therapeutic Approaches  
    Sanjay Mathew, Jordan F Karp, Nature

Authored Content

  • F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018
  • F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018

Press Mentions

  • Matthew Perry’s Death Shines a Harsh Light on Ketamine Treatment
    Matthew Perry’s Death Shines a Harsh Light on Ketamine TreatmentAugust 19th, 2024
  • Researchers Discover Positive Effects of Intravenous Ketamine for Treatment-Resistant Depression
    Researchers Discover Positive Effects of Intravenous Ketamine for Treatment-Resistant DepressionMay 25th, 2023
  • Treatment for Anxiety: Medications and Options
    Treatment for Anxiety: Medications and OptionsApril 6th, 2023
  • Join now to see all

Grant Support

  • 2/2 A brief automated neurocognitive training to enhance the real-world impact of ketamine's rapid antidepressant effectBAYLOR COLLEGE OF MEDICINE2024–2029
  • 2/2 A brief automated neurocognitive training to enhance the real-world impact of ketamine's rapid antidepressant effectBAYLOR COLLEGE OF MEDICINE2024–2029
  • Gamma oscillations as a prognostic marker for ketamine therapy in treatment resistant depressionBAYLOR COLLEGE OF MEDICINE2024–2025
  • Gamma oscillations as a prognostic marker for ketamine therapy in treatment resistant depressionBAYLOR COLLEGE OF MEDICINE2024–2025
  • Optimization Of IV Ketamine For Treatment Resistant Major DepressionNational Institute Of Mental Health2010–2012
  • 2/3-Efficacy And Tolerability Of Riluzole In Treatment-Resistant DepressionNational Institute Of Mental Health2010–2012
  • Optimization Of IV Ketamine For Treatment Resistant Major DepressionNational Institute Of Mental Health2009
  • Optimization Of IV Ketamine For Treatment Resistant Major DepressionNational Center For Research Resources2009
  • Continuation Riluzole In Prevention Of Relapse Following Ketamine In DepressionNational Center For Research Resources2007–2009
  • MRS Neurometabolites In Chronic Fatigue Syndrome, GAD And Healthy VolunteersNational Center For Research Resources2008
  • Proton MRS Studies In Generalized Anxiety DisorderNational Institute Of Mental Health2004–2008
  • MRS Neurometabolites In Chronic Fatigue Syndrome, GAD, And Healthy VolunteersNational Center For Research Resources2007
  • Adenocine Receptor Polymorphisms And Physiologic Response To Caffeine In PDNational Center For Research Resources2006
  • MRS Neurometabolites In Chronic Fatigue Syndrome, Generalized Anxiety DisorderNational Center For Research Resources2005–2006

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: